898227-93-5

Basic information

• Product Name: 5-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID
• Synonyms: 5-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID;5-ethyloxazole-4-carboxylic acid;5-ethyl-1,3-oxazole-4-carboxylic acid(SALTDATA: FREE)
• CAS NO: 898227-93-5
• Molecular Formula: C6H7NO3
• Molecular Weight: 141.13
• Mol File: 898227-93-5.mol

Chemical Properties

• Boiling Point: 269.7°C at 760 mmHg
• Flash Point: 116.9°C
• Appearance: /
• Density: 1.273g/cm³
• Vapor Pressure: 0.00353mmHg at 25°C
• Refractive Index: 1.509
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 5-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID(898227-93-5)
• EPA Substance Registry System: 5-ETHYL-1,3-OXAZOLE-4-CARBOXYLIC ACID(898227-93-5)

Safety Data

• Hazardous Substances Data: 898227-93-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
5-Ethyl-1,3-oxazole-4-carboxylic acid is utilized as a building block for the development of new drugs. Its unique structure and properties contribute to the creation of innovative pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Development:
In addition to its pharmaceutical applications, 5-Ethyl-1,3-oxazole-4-carboxylic acid also serves as a precursor in the development of new agrochemicals. Its role in the synthesis of bioactive compounds makes it valuable for creating effective and novel agricultural products.
Used in Organic Synthesis:
5-Ethyl-1,3-oxazole-4-carboxylic acid is employed as a key component in organic synthesis processes. Its versatility and reactivity make it an essential building block for the creation of a wide range of organic compounds with diverse applications across various industries.

InChI:InChI=1/C6H7NO3/c1-2-4-5(6(8)9)7-3-10-4/h3H,2H2,1H3,(H,8,9)

Upstream product

• 32968-45-9 ethyl 5-ethyl-1,3-oxazole-4-carboxylate 

Relevant articles and documents

Widely Exploited, Yet Unreported: Regiocontrolled Synthesis and the Suzuki–Miyaura Reactions of Bromooxazole Building Blocks

An approach to synthesis of 2-, 4-, and 5-bromooxazoles is described. The method was optimized, and its scope was extended to all three isomeric parents, as well as various alkyl- and aryl-substituted bromooxazoles. It was found that direct regiocontrolled lithiation followed by reaction with electrophilic bromine source was common for all substrates and led exclusively to the target substituted 2-, 4- and 5-bromooxazoles on multigram scale. The utility of the multipurpose building blocks obtained in this work was demonstrated in the Suzuki–Miyaura cross-coupling reaction under parallel synthesis conditions.

NOVEL PHARMACEUTICALS

The present invention relates to immune response modifiers of formula (I), which act selectively through agonism, of Toll-Like Receptors (TLRs), uses thereof, processes for the preparation thereof, intermediates used in the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including the treatment of infectious disease such as Hepatitis (e.g. HCV, HBV), genetically related viral infection and cancer.

NOVEL PYRIDINE COMPOUNDS

The present invention relates to certain novel pyridin compounds of Formula ( I ) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, and processes for their preparation, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.